These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 671851)

  • 21. [Results of associated immunosuppressive -- antiphlogistic treatment of proliferative glomerulonephritis (author's transl)].
    Szewczyk Z; Szepietowski T; Falkiewicz K; Rabczyński J
    Przegl Lek; 1976; 33(5):550-4. PubMed ID: 948642
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of steroid-resistant nephrotic syndrome. Physiopathology and treatment in childhood (author's transl)].
    Okada T
    Nihon Jinzo Gakkai Shi; 1975 May; 17(5):341-6. PubMed ID: 1241024
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].
    Takasaki H; Shibata M
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1271-80. PubMed ID: 7035725
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies of plasma active and inactive renins in patients with nephrotic syndrome. Part V. Relationships between plasma renins, pathological findings and therapeutic response in patients with nephrotic syndrome (author's transl)].
    Tsai TJ
    Taiwan Yi Xue Hui Za Zhi; 1981 Nov; 80(11):1145-51. PubMed ID: 7035611
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on antinephritic action of dipyridamole (1). The effect of dipyridamole on anti-GBM induced nephritis in rats (author's transl)].
    Suzuki Y; Ito M
    Nihon Jinzo Gakkai Shi; 1981 Mar; 23(3):323-32. PubMed ID: 7311118
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
    Shearman JD; Yin ZG; Aarons I; Smith PS; Woodroffe AJ; Clarkson AR
    Clin Nephrol; 1988 Dec; 30(6):320-9. PubMed ID: 3243041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon.
    van der Meer J; Wouda AA; Kallenberg CG; Wesseling H
    Vasa Suppl; 1987; 18():71-5. PubMed ID: 3299819
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical effect of dipyridamole ingestion after prosthetic heart valve replacement--especially on the blood coagulation system (author's transl)].
    Kasahara T
    Nihon Kyobu Geka Gakkai Zasshi; 1977 Aug; 25(8):1007-21. PubMed ID: 925445
    [No Abstract]   [Full Text] [Related]  

  • 29. [Approach to the treatment of intractable nephrotic syndrome].
    Nihon Jinzo Gakkai Shi; 1986 Jul; 28(7):983-95. PubMed ID: 3795609
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of cyclophosphamide on the reproductive function -- study of testicular histology in male patients with nephrotic syndrome (author's transl)].
    Ogata H; Shibata T; Hirai Y; Aratani H; Yokoyama K; Shinzato K; Taura K; Harada T; Fujimatsu S; Horita S; Hara K; Shindo K; Matsuo T; Nakayama I
    Nihon Jinzo Gakkai Shi; 1981 Feb; 23(2):213-21. PubMed ID: 7253320
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ifosfamide in the treatment of nephrotic syndrome (author's transl)].
    Gekle D; Daigeler C
    Klin Padiatr; 1977 Sep; 189(5):370-5. PubMed ID: 562447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dipyridamole on the domestic gas intoxication (author's transl).
    Ojeda-Sahagun JL
    Rev Esp Fisiol; 1971 Dec; 27(4):305-10. PubMed ID: 5173030
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thrombotic thrombocytopenic purpura--successful treatment by warfarin and antiplatelet drugs (author's transl)].
    Nagata S; Kosaka H; Sadamoto H
    Rinsho Ketsueki; 1981 May; 22(5):678-84. PubMed ID: 7196966
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ig synthesis of lymphocytes from idiopathic nephrotic syndrome patients (author's transl)].
    Kumon S; Okura T; Hibi I; Matsuo S; Tamaki S; Sakamoto N
    Nihon Jinzo Gakkai Shi; 1981 Oct; 23(10):1291-34. PubMed ID: 7334714
    [No Abstract]   [Full Text] [Related]  

  • 35. [An adult case of hemolytic-uremic syndrome treated with inhibitors of platelet functions (author's transl)].
    Mori H
    Rinsho Ketsueki; 1979 Nov; 20(11):1475-81. PubMed ID: 537167
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical course and recurrences of the nephrotic syndrome due to minimal histologic lesions. Review of 73 cases (author's transl)].
    Vázquez Tadei G; Fernández J; Martin Malo A; Campdera FG; Sanz Guajardo D; Traver JA; Botella J
    Med Clin (Barc); 1979 May; 72(10):401-4. PubMed ID: 470486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antithrombotic drug treatment of glomerulonephritis].
    Krasik IaD; Zorina SS; Orlova NN
    Vrach Delo; 1981 Jul; (7):17-9. PubMed ID: 7281606
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclophosphamide therapy in the management of nephrotic syndrome.
    Srivastava RN; Mayekar G; Anand R; Choudhry VP; Ghai OP
    Indian Pediatr; 1974 Dec; 11(12):767-74. PubMed ID: 4448539
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of leukeran in the treatment of nephrotic syndrome in children].
    Kucharska K; Sancewicz-Pach K
    Pediatr Pol; 1978 Aug; 53(8):973-8. PubMed ID: 693147
    [No Abstract]   [Full Text] [Related]  

  • 40. [Symposium on edema. (2) Clinics of edema. II) Neophrotic syndrome (author's transl)].
    Ogura Y; Ishimoto F
    Nihon Naika Gakkai Zasshi; 1978 Nov; 67(11):1334-41. PubMed ID: 731102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.